Clinical studies with B72. 3 in ovarian cancer and probe-guided tumor localization(811 views) Del Vecchio S, Camera L, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1991; 18(1): 85-87.
Affiliations: Nuclear Medicine Department, National Cancer Institute, Institute of Nuclear Medicine, Naples, Italy
Oncology Division, II School of Medicine, Naples, Italy
Istituto di Medicina Nucleare, II Facolta' Medicina/Chirurgia, Via S. Pansini 5, I-80131 Napoli, Italy
References: Not available.
Clinical studies with B72. 3 in ovarian cancer and probe-guided tumor localization
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(458 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote